Shire U.S., Inc. v. Blackburn
Certiorari Denied
Petition for certiorari denied on October 2, 2023.
Issue
Whether a state-law claim is preempted if it places a duty on a drug manufacturer to unilaterally change language approved by the Food and Drug Administration that appears in the highlights section of a drug label.
Mar 21, 2023Application (22A846) to extend the time to file a petition for a writ of certiorari from April 5, 2023 to May 5, 2023, submitted to Justice Thomas.
Mar 29, 2023Application (22A846) granted by Justice Thomas extending the time to file until May 5, 2023.
Apr 18, 2023Application (22A846) to extend further the time from May 5, 2023 to June 4, 2023, submitted to Justice Thomas.Apr 25, 2023Application (22A846) granted by Justice Thomas extending the time to file until June 4, 2023.
Jun 2, 2023Petition for a writ of certiorari filed. (Response due July 7, 2023)Jun 22, 2023Motion to extend the time to file a response from July 7, 2023 to August 7, 2023, submitted to The Clerk.Jun 23, 2023Motion to extend the time to file a response is granted and the time is extended to and including August 7, 2023.
Jul 7, 2023Amicus brief of Pharmaceutical Research Manufacturers of America not accepted for filing (duplicate electronic filing). (July 12, 2023)
Jul 7, 2023Brief amicus curiae of Pharmaceutical Research Manufacturers of America filed.Jul 12, 2023Brief of respondent Mark Blackburn in opposition filed.Jul 26, 2023DISTRIBUTED for Conference of 9/26/2023.
Jul 26, 2023Reply of petitioners Shire US Inc., et al. filed. (Distributed)Oct 2, 2023Petition DENIED.
Recommended Citation: Shire U.S., Inc. v. Blackburn, SCOTUSblog, https://www.scotusblog.com/cases/shire-u-s-inc-v-blackburn/